Physician profile
Albert Geskin
NPI 1124556972
$13,429.45
in general payments reported to CMS, 2019-2025
39 companies · $7,057 in 2025
The $7,057 reported for 2025 was more than what 92% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $327 · 2023: $1,658 · 2024: $4,388 · 2025: $7,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,939 · Consulting Fee: $3,080 · Education: $2,600 · Travel and Lodging: $1,483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,938.86 |
| Consulting Fee | $3,080.00 |
| Education | $2,599.99 |
| Travel and Lodging | $1,483.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $4,009.32 | 2024-2025 | Erleada, Balversa, Akeega |
| Intuitive Surgical, INC. | $3,607.31 | 2023-2025 | Da Vinci Surgical System |
| Sumitomo Pharma America, INC. | $1,000.18 | 2023-2025 | Orgovyx, Gemtesa |
| Boston Scientific Corporation | $615.11 | 2022-2025 | Ams 700, Axonics, Rezum Generator |
| Janssen Biotech, INC. | $486.86 | 2023-2025 | Erleada |
| Astellas Pharma US INC | $306.69 | 2023-2025 | Xtandi, Myrbetriq |
| Dendreon Pharmaceuticals LLC | $303.67 | 2023-2024 | Provenge |
| Medtronic, INC. | $267.24 | 2023 | Interstim, Signia |
| Verity Pharmaceuticals INC. | $202.37 | 2024-2025 | Trelstar |
| Agiliti Surgical, INC. | $199.26 | 2023-2025 | Koelis Trinity Mri/US Fusion, Sonablate Hifu, Sonablate |
| Endo USA, INC. | $184.46 | 2024-2025 | Xiaflex, Aveed |
| Olympus America INC. | $175.80 | 2023-2025 | Itind System, Olympus |
| Sight Sciences, INC. | $144.20 | 2024 | Omni Surgical System |
| Tolmar, INC. | $139.61 | 2023-2025 | Eligard, Jatenzo |
| Teleflex LLC | $137.21 | 2022-2025 | Urolift |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $128.64 | 2024-2025 | |
| Davol INC. | $123.43 | 2022 | |
| Coloplast Corp | $121.79 | 2023-2025 | Titan |
| Novartis Pharmaceuticals Corporation | $119.42 | 2024-2025 | |
| Baxter Healthcare | $119.04 | 2023 | Tisseel |
| Merck Sharp & Dohme LLC | $112.62 | 2024-2025 | Keytruda |
| Ferring Pharmaceuticals INC. | $101.31 | 2023-2025 | Adstiladrin |
| Astrazeneca Pharmaceuticals LP | $99.46 | 2023-2025 | Lynparza |
| Antares Pharma, INC. | $91.18 | 2024-2025 | Xyosted |
| Johnson & Johnson Health Care Systems INC. | $88.02 | 2025 | Erleada |
| Endo Pharmaceuticals INC. | $67.67 | 2023-2024 | Xiaflex, Aveed |
| Urogen Pharma, INC. | $62.69 | 2023-2025 | Jelmyto |
| Accord Healthcare, INC. | $48.31 | 2023 | |
| Cook Medical LLC | $45.53 | 2025 | Cook |
| Axonics, INC. | $43.53 | 2023 | Axonics |
| Myriad Genetic Laboratories, INC. | $42.89 | 2023 | Prolaris |
| Ethicon US, LLC | $40.94 | 2024 | Stratafix |
| Bayer Healthcare Pharmaceuticals INC. | $39.29 | 2023 | |
| Civco Medical Instruments | $39.29 | 2025 | |
| Procept Biorobotics Corporation | $29.64 | 2023-2025 | Aquabeam Robotic System |
| Laborie Medical Technologies Corp. | $24.68 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Immunitybio, INC. | $22.25 | 2024 | |
| Azurity Pharmaceuticals, INC. | $20.71 | 2025 | Azmiro |
| Ambu INC. | $17.83 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Geskin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.